INTRUCTIONS FOR AUTHORS (Updated - September 2025)

The Jornal Brasileiro de Pneumologia (JBP, Brazilian Journal of Pulmonology), ISSN 1806-3756, is the official publication of the Brazilian Thoracic Association (SBPT). It operates on a rolling basis and focuses on disseminating scientific research related to pulmonology and associated fields. The JBP is indexed in PubMed (www.ncbi.nlm.nih.gov/pmc/journals/2395) and SciELO (https://www.scielo.br/).

Following an initial assessment by the Editors, manuscripts may be forwarded to qualified reviewers at the discretion of the Editor and the Editorial Board. Anonymity for both authors and reviewers will be maintained throughout the review process, except when a manuscript has been previously archived on a preprint server. In such cases, the JBP adopts a single-blind peer-review system, where authors remain unaware of the reviewers' identities. Manuscripts that lack sufficient merit or novelty, fall outside the scope of the JBP, contain methodological inaccuracies that compromise internal validity, or do not align with the JBP's editorial policy will be rejected outright by the Editorial Board, with no opportunity for appeal.

All manuscripts must be submitted in English, with either American or British usage acceptable, provided that the two are not mixed. It is crucial that the text is composed in high-quality English. Authors who are not fluent in English are encouraged to have their manuscripts edited by a professional editing service or reviewed by a native English-speaking prior to submission. However, utilizing a professional editing service is not a requirement for publication in the Journal and does not assure that the article will be sent for review or accepted. Upon submission, each manuscript will be assigned a unique manuscript number for future reference.

*No fees are charged for article submission or processing, and eventual publication.

The JBP adheres to the policies set forth by the World Health Organization (WHO) and the International Committee of Medical Journal Editors (ICMJE) regarding the registration of clinical trials, acknowledging the significance of these initiatives for the registration and open-access dissemination of clinical trial information. Consequently, the JBP accepts only those clinical trials that have been registered with clinical trial registries meeting the criteria established by WHO and ICMJE. Links to these registries can be found on the ICMJE website (ICMJE-hptt://www.ICMJE.org). The registry identifier must be included at the end of the abstract.

Within this context, JBP aligns with the World Health Organization's (WHO) definition of a clinical trial, summarized as follows: "a clinical trial is any research study that prospectively assigns human subjects to one or more interventions to assess the effects of those interventions on health-related outcomes. These interventions involve the administration of drugs, cells, and other biological products, along with surgical procedures, radiological techniques, the use of medical devices, behavioural therapies, alterations in treatment processes, and preventive care measures."

In any human studies, the Methods section should clearly state that the research was approved by the relevant local or national research ethics committee, ideally including the reference number, and that the study was conducted in accordance with the Declaration of Helsinki. Experimental animal studies fall outside the scope of the JBP.

Manuscripts submitted to the JBP are accepted for consideration on the condition that they have not been previously published and are not under review elsewhere. The JBP utilizes Crossref Similarity Check software (iThenticate) to evaluate the similarity between submitted manuscripts and previously published articles.

First submission to the JBP, required documents:
 

1. Covering letter
2. Title page: list authors with affiliations, ORCID-ID, describe the contribution of each author, corresponding author's contact details, keywords.
3. Manuscript
4. Figures, tables or images
5. Authors statement form
6. Declaration of interest and funding
7. Mention any previous submissions or correspondence with other journals
8. If applicable, mention prior submissions and any feedback received from other journals.
9. A statement confirming approval from the relevant ethics board.
10. The reference or approval number.

AUTHORSHIP

All listed authors must meet the four criteria for authorship outlined in the ICMJE Recommendations 2024 (http://www.ICMJE.org). These criteria are:

1. Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
2. Drafting the work or providing critical review for significant intellectual content; AND
3. Final approval of the version to be published; AND
4. Accountability for all aspects of the work, ensuring that any questions regarding the accuracy or integrity of any part of the work are appropriately addressed.

Each author should clearly outline their specific contributions to the manuscript. Additionally, any conflicts of interest should be disclosed transparently after the acknowledgments section, enabling readers to assess the potential impact of external influences on the study results. For conflict statement click here.

Data collection and subject recruitment alone do not qualify for authorship. Similarly, authorship should not be granted to technicians conducting routine tasks, referring physicians, doctors interpreting standard exams, or department heads not directly involved in the research. Contributions from these individuals may be acknowledged in a dedicated section at the end of the manuscript (before the references). The specific contributions of each author and any acknowledgments must be clearly stated on the title page (see Title Page).
 
The JBP accepts up to 15 authors for original articles who qualify for authorship, though exceptions may be made for more complex papers. For each submitted manuscript, a description of each author's contributions must follow the title and authorship section. The authors are solely responsible for the accuracy of all concepts presented in the manuscript.
 
The use of Artificial Intelligence (AI) must be disclosed at the time of submission, and the JBP adheres to the ICMJE Recommendations 2024 (http://www.ICMJE.org) regarding AI in research. Chatbots, such as ChatGPT, should not be listed as authors since they cannot be held accountable for the accuracy, integrity, and originality of the work-responsibilities that are essential for human authorship.

Assisted technologies, including Large Language Models (LLMs), chatbots, or image creators, used in the creation of submitted work must be clearly disclosed. Authors utilizing such technologies should describe their usage in both the cover letter and the appropriate sections of the manuscript, if applicable. If AI is employed for data collection, analysis, or figure generation, this must be detailed in the Methods section. Authors are encouraged to meticulously review and edit AI-generated content, as it may be incorrect, incomplete, or biased.

Furthermore, authors must ensure there is no plagiarism in their work, including text and images generated by AI, and they bear full responsibility for all generated and quoted material, as well as complete citations. The JBP does not accept images or figures that have been enhanced by AI. Any use of AI for writing assistance should be acknowledged in the acknowledgment section.

TYPE OF ARTCLES AND SPECIFICATIONS
 
Main text files should be submitted in Word (.doc or .docx). All types of studies must follow Equator Guidelines for the specific study. Main text files should be submitted in Word (.doc or .docx). The table below shows a summary of specifications for the types of manuscripts that can be submitted to the JBP.  Guidelines, Consensus and Recommendations submission information click here.

 

Manuscript type	Abstract, words max.	Body of text, words max.	References max.	Tables, charts, figures, max.	Supplementary Material
Original Articles	250 structured	3,000	40	= 8	Accepted
Systematic Reviews with Meta-analyses	250 structured	5,000	80	8	Accepted
Letters to the Editor	No abstract	1,200	15	2	Not accepted
Observational Studies	250 structured	3,000	40	8	Accepted
Pictorial Essays	250 unstructured	3,000	30	12	Not Accepted
Special Article: task force, guidelines, recommendations and consensus	250 unstructured	8,000	200	15	Accepted
Systematic Reviews	250 structured	4,000	80	=8	Accepted
Narrative Reviews Articles	250 unstructured	4,000	80	=5	Accepted
Editorials	No abstract	1,500	30	2	Not accepted
State of art	250 unstructured	5000	200	8	Accepted
Viewpoint	No abstract	2,000	30	2	Not accepted
Images in Pulmonary Medicine	No abstract	250	5	1	Not accepted
Limited series	250 unstructured	2000	200	5	Accepted
Continuing education	No abstract	800	5	1	Not accepted
Correspondence	2000	200	5	Accepted	2000

 


Original Articles

For original articles, the main text (excluding the abstract, references, and illustrations such as tables, charts, and figures) should not exceed 3,000 words. Illustrations are limited to a total of 8, and the number of references must not exceed 40. The structure of the main text should be as follows: Introduction, Methods, Results, Discussion, Acknowledgments, and References. The JBP accepts up to 15 authors for original articles who qualify for authorship, though exceptions may be made for more complex papers.

The Methods section must include a statement confirming that the study was approved by the relevant human or animal research ethics committee. It should also detail the study design, recruitment and sampling, study definition, methodology, sample size calculation, statistical analysis, and provide appropriate references of each topic. Subheadings are permitted in the Methods and Results sections, provided they are used judiciously; however, they are not allowed in the Introduction or Discussion sections.

The following types are the most common articles considered original and should follow the Equator Reporting Guidelines (https://www.equator-network.org)

1. Randomized controlled trials
2. Systematic reviews with meta-analysis
3. Letters to the editor
4. Real-life studies
5. Cohort studies
6. Case-control studies
7. Cross-sectional studies
8. Pictorial essays
9. Diagnostic test studies
10. Prognostic studies
11. Survey with high response rate
 
1. Randomized Controlled Trials (RCT) 
Randomized Controlled Trials (RCTs) are studies in which the intervention is randomly assigned to participants. These trials may be double-blinded, cross-over, noninferiority, or pragmatic (randomized non-blinded studies) among others. All RCTs must adhere to the CONSORT Statement (https://www.equator-network.org/reporting-guidelines/consort/).

 2. Systematic Reviews with Meta-analyses
For systematic reviews with meta-analyses, the abstracts should be structured similarly to those for original articles. The main text (excluding the unstructured abstract, references, and illustrations) should not exceed 4,000 words, with a total of no more than 8 tables and/or illustrations. The number of references is limited to 80. Systematic reviews with meta-analyses must be registered with the Cochrane Library or PROSPERO and should adhere to the PRISMA Statement (https://www.equator-network.org/reporting-guidelines/prisma/).

3. Observational studies
Observational studies encompass real-life studies, cohort studies, case-control studies, and cross-sectional studies, epidemiological assessment, pictorial essays
diagnostic test studies, prognostic study, survey with high response rate. Findings from observational studies should be reported in accordance with the STROBE guidelines (https://www.equator-network.org/reporting-guidelines/strobe/).
 
3.1  Real Life Studies
Real life studies are observational effectiveness studies often referred to as "real-life" or "real-world" investigations, as they strive to more closely reflect actual patients and clinical practice compared to traditional randomized controlled trials (RCTs). These studies generally fall into two classifications: (1) observational studies that utilize clinical, claims, and/or administrative databases, and (2) pragmatic trials, which differ from RCTs by employing more generalizable inclusion criteria and implementable management approaches. They should be no longer than 3,000 words, with up to 40 references and 8 illustrations.
 
3.2  Cohort studies
An observational study aimed at determining the association between an exposure and an outcome. It involves selecting participants based on their outcomes. Participants with the outcome (cases) are compared to those without the outcome (controls) concerning a specific exposure or event. Cases and controls may be matched based on particular characteristics, such as age, sex, or duration of the disease. The inception point in the study is a crucial methodological aspect that helps to avoid unwanted bias concerning prognosis. Properly defining this point ensures that the study accurately reflects the temporal relationship between exposure and outcome, thereby enhancing the validity of the findings. These studies should be no longer than 3,000 words, with up to 40 references and 8 illustrations.
 
3.3  Case-control studies
An observational study aimed at determining the association between an exposure and an outcome that involves selecting participants based on their outcomes. Participants with the outcome (cases) are compared to those without the outcome (controls) regarding a specific exposure or event. Cases and controls may be matched based on certain characteristics, such as age, sex, or duration of illness. They usually involve rare diseases. This type of study should be no longer than 3,000 words, with up to 40 references and 8 illustrations
 
3.4  Cross-sectional studies
A cross-sectional study is an observational study of a defined population conducted at a single point in time or over a specific interval, assessing both exposure and outcome simultaneously. These studies are valuable for exploring associations and generating hypotheses; however, they cannot establish causality. This type of study should be no longer than 3,000 words, with up to 40 references and 8 illustrations.
 
3.5  Pictorial Essays
A pictorial essay is an educational article designed to provide both textual and visual representations of a topical issue. It typically includes a short unstructured abstract, a brief introduction, subheadings to organize the content, and a summary. Pictorial essays are by invitation or by permission from the Editorial Board. The text (excluding references and illustrations) should be no longer than 3,000 words. The total number of illustrations should be limited to 12, and the number of references should not exceed 30. The primary criteria for publication are relevance, educational value and high quality of illustrations. This type of study should be no longer than 3,000 words, with up to 40 references and 8 illustrations.
 
3.6  Diagnostic Study
A diagnostic accuracy study assesses the ability of one or more medical tests to accurately classify participants as having a target condition. This target condition may include a specific disease, disease stage, response to therapy, or a future event or condition. Medical tests can encompass imaging procedures, laboratory tests, components from history and physical examinations, or combinations of these methods, aimed at gathering information about a patient's current health status. This type of prospective study is designed to develop, validate, or update the diagnostic or prognostic accuracy of a test or model and requires and index test to evaluate accuracy. Follow STARD Reporting Guidelines for diagnostic studies (https://www.equator-network.org/reporting-guidelines/stard/). These studies should be no longer than 3,000 words, with up to 40 references and 8 illustrations.
 
3.7  Prognostic study
Prediction models are utilized in various healthcare settings to estimate outcomes or risks. Most models are designed to assess the probability of a particular health condition's presence (diagnostic) or to determine whether a specific outcome will occur in the future (prognostic). Their primary purpose is to support clinical decision-making, guiding actions such as whether to refer patients for further testing, monitor disease progression or treatment effects, or initiate treatment or lifestyle changes. For prognostic studies use TRIPOD Reporting Guidelines (https://www.equator-network.org/reporting-guidelines/tripod-statement/).
These studies should be no longer than 3,000 words, with up to 40 references and 8 illustrations.
 
3.9  Survey with high response rate
A survey study includes a representative sample of individuals who are asked to describe their opinions, attitudes, or behaviours. Survey studies should have sufficient response rates (generally =60%) and appropriate characterization of nonresponders to ensure that nonresponse bias does not threaten the validity of the findings. This type of study should be no longer than 3,000 words, with up to 40 references and 8 illustrations.
 
OTHER SUBMISSIONS

1.  Especial articles: Task force, SBPT recommendations, Grade Guidelines, and Consensus.
 
These publications by SBPT focus on critical issues in clinical medicine, public health, health policy, and medical research. They are developed in a scholarly, comprehensive, and well-referenced format. The content is systematically organized and evidence-based, reflecting a rigorous approach to the subject matter. Instructions for Task Force, Guidelines, Recommendations and Consensus submissions information click here.
 
Manuscripts are preferred to be based on PICO questions, systematic reviews with meta-analysis, and GRADE evaluation. When not possible, alternatives include systematic reviews without meta-analysis and narrative reviews. Authors are encouraged to submit a proposal to the journal; upon evaluation, a determination will be made regarding the continuation of the project.

The main text (excluding the unstructured abstract, references, and illustrations) must not exceed 8,000 words, and the total number of illustrations should be limited to 15. Additionally, the number of references is capped at 200. These narrative reviews should accurately represent the current state of the art on the subject.
 
2.  Narrative Reviews
The reviews should provide an up-to-date overview for clinicians on topics of general interest, written from the perspective of internationally recognized experts in the respective disciplines. The focus should be on updating the current understanding of the disease or condition's physiology, diagnostic considerations, and treatment options. Additionally, these reviews should address specific questions or issues relevant to clinical practice. Narrative reviews are subject to invitation. The abstract is unstructured, the maximum of words is 4000, with up 100 references and =5 illustration. These are made by invitation only.
 
3.  State of art
State-of-the-Art articles are extensive, scholarly works that provide a broad and comprehensive examination of significant recent advancements in respiratory medicine. These articles typically use up to 5,000 words, 8 figures or tables and up 200 references. The abstract should be concise, containing 250 words, and should be informative rather than merely descriptive. Authors are required to submit a 500-word outline to the Publisher as part of a pre-submission inquiry.

State-of-the-Art articles are comprehensive scholarly works that thoroughly examine significant recent advancements in respiratory medicine. Typically, these articles may contain up to 5,000 words, include a maximum of 8 figures or tables, and up to 200 references. The abstract should be concise, limited to 250 words, and should provide informative content rather than a mere description. Authors must submit a 500-word outline to the Editorial Board as part of the pre-submission inquiry process. By invitation only.
 
4.  Viewpoint
Refers to a particular attitude, perspective, or opinion regarding a specific subject or issue. It encompasses the lens through which one interprets information or experiences, often influenced by personal beliefs, values, and experiences. When presenting a viewpoint, it is important to support it with reasoned arguments and evidence to enhance credibility and foster meaningful discussion. They should be no longer than 2,000 words, with up to 30 references and 2 illustrations. By invitation only.
 
5.  Editorials
Editorials are only by invitation. The text (excluding references and illustrations) should be no longer than 1,500 words. The total number of illustrations is 2, and the number of references should not exceed 30. By invitation only.

 6.  Images in Pulmonary Medicine
For images in pulmonary medicine, the text, including the title and the body of text, should be limited to 200 words, with up to 3 references. Authors should include only 1 figure with up to 5 images, bearing in mind that the entire document will be published on a single page.
 
7.  Letters to the Editor
Letters to the editor are original contributions original studies or evaluations or of unique, first-time reports of clinical case series or rare case series. They should be no longer than 1,200 words, with up to 15 references and 2 illustrations. Please note that case reports are accepted only in exceptional circumstances. These criteria ensure clarity and focus while allowing for meaningful contributions to the literature.

 8.       Preprints
The JBP accepts submissions of articles deposited on preprint servers. For these articles, the peer-review process will be single-blind. The corresponding author must complete an authorization form stating that the article submitted was previously deposited on a preprint server.

9.  Correspondence
Correspondence serves as a platform for submitting comments, questions, or criticisms regarding published articles. Authors of the discussed articles are expected to address criticisms using the same medium and should be prompted by editors to respond. Authors of correspondence must declare any competing interests or relationships.  Correspondence may be edited for length, grammar, and adherence to journal style. The journal will reject comments that are discourteous, inaccurate, or libelous. Responsible debate, critique, and disagreement are encouraged. Submissions should not exceed 500 words, with a maximum of 5 references and 1 figure or table.
These guidelines promote respectful and constructive dialogue within the academic community.
 
PRESENTATIONS AND SUBMISSIONS OF MANUSCRIPTS

Manuscripts must be submitted electronically via the ScholarOne submission system: https://mc04.manuscriptcentral.com/jbpneu-scielo. The instructions and submission process are described below: The copyright transfer form must be electronically signed by each of the authors and uploaded to the ScholarOne. The form is available here.


Authors are requested to follow the JBP editorial guidelines carefully, especially regarding the maximum number of words, tables, charts, and figures allowed, as well as the preparation of references. Failure to comply with the instructions for authors will result in the manuscript being returned to the authors so that the pertinent corrections can be made before it is submitted to the reviewers.

Special instructions apply to the preparation of guidelines and consensus statements, and authors should consult these instructions on the JBP homepage before preparing such documents. Guidelines and consensus statements will be published on a rolling basis as special articles.

The JBP reserves the right to make stylistic, grammatical, and other changes on accepted manuscripts.
 
Title Page 
The title page should include the title of the paper (in English); the names and institutional affiliations of all authors; the complete address, including telephone number, fax number, and e-mail address, of the corresponding author; and, if applicable, the name of the funding body and the funding identifier. The Open Researcher and Contributor ID (ORCID) of each author should be provided. For instructions on how to obtain an ORCID, visit https://orcid.org/. The places where the study was conducted should be included. In addition, the contribution of each author to the study and any acknowledgments must be included on the title page. Acknowledgments and contributions will be published at the end of the body of the manuscript, before the references. The title page should be sent as a separate Word file.

Abstract 
The abstract should present information in such a way that readers can easily understand it without referring to the main text and should not exceed 250 words. Abstracts for original articles and meta-analyses should be structured with the following headings: Objective, Methods, Results, and Conclusions. Abstracts for review articles and pictorial essays should be unstructured.

Keywords
Authors should provide three to six keywords in English describing the subject of the paper. Keywords must be taken from the Medical Subject Headings (MeSH) list, available at http://www.nlm.nih.gov/mesh/MBrowser.html

Body of text
Abbreviations other than those for units of measure should be avoided as much as possible and only widely accepted abbreviations should be used. The JBP provides a list of abbreviations and acronyms accepted without definition (List of Abbreviations and Acronyms). Abbreviations other than those on the JBP list are allowed if the term to be abbreviated is used at least three times (in the abstract and in the body of text). Such abbreviations must be defined at first mention-for example, C-reactive protein (CRP). Thereafter, the term in full should not be used. Single-word terms-such as tuberculosis (TB)-should not be abbreviated.
 
Whenever any substance or uncommon piece of equipment is mentioned in the text, authors should include the catalogue number/model, the name of the manufacturer, and the city/country of origin. For example: "...ergometric treadmill (model ESD-01; FUNBEC, São Paulo, Brazil)." For products coming from the United States or Canada, the name of the state or province should also be included. For example: "... guinea pig liver tTg (T5398; Sigma, St. Louis, MO, USA)."

Tables, Charts, and Figures (Illustrations)
All tables, charts, and figures should be in black and white. Illustrations should be submitted electronically in their original format. Tables should be submitted as Microsoft Word files, whereas figures should be submitted as JPEG files, with a resolution of at least 300 dpi. Photographs depicting surgical procedures, as well as those showing the results of exams or biopsies, in which staining and special techniques were used, will be considered for publication in colour, at no additional cost to authors. All tables and figures should be numbered with Arabic numerals in the order of their appearance in the text.
 
Legends
 Legends should accompany all illustrations. Legends for figures (graphs, photographs, etc.) should be placed below the corresponding figures, which should be submitted in Word files. Titles for tables and charts should be placed at the top of the corresponding illustrations. All legends should be numbered with Arabic numerals in the order of their appearance in the text. Footnotes should be as follows: first, spell out all abbreviations, acronyms, and symbols; indicate details and extra information regarding the illustration with lower-case, superscript letters-e.g., Values expressed as n (%); and indicate statistics with typographic characters, all of which but * should be superscript-e.g., *p < 0.05. Typographic characters should be used in the following sequence: *; ┼; ┼┼; ¶; §; ||; and #.

References
References should be listed in the order of their appearance in the text and should be numbered consecutively with Arabic numerals. When referencing in the text, avoid names of authors-instead, use "one study" or "one author/group of authors", for example. References should be presented in Vancouver Style, as illustrated below. Journal titles should be abbreviated according to the Index Medicus list, available at https://www.ncbi.nlm.nih.gov/nlmcatalog/journals/. All authors should be listed when there are six or fewer. When there are more than six authors, list the first six, followed by "et al."
 
Examples:
 
Original Articles

1. Neder JA, Nery LE, Castelo A, Andreoni S, Lerario MC, Sachs AC et al. Prediction of metabolic and cardiopulmonary responses to maximum cycle ergometry: a randomized study. Eur Respir J. 1999;14(6):1204-13.

 
Abstracts
2. Singer M, Lefort J, Lapa e Silva JR, Vargaftig BB. Failure of granulocyte depletion to suppress mucin production in a murine model of allergy [abstract]. Am J Respir Crit Care Med. 2000;161:A863.

 
Chapter in a Book

3. Queluz T, Andres G. Goodpastures syndrome. In: Roitt IM, Delves PJ, editors. Encyclopedia of Immunology. 1st ed. London: Academic Press; 1992. p. 621-3.
 
Official Publications

4. World Health Organization. Guidelines for surveillance of drug resistance in tuberculosis. WHO/Tb, 1994;178:1-24.
 
Theses
5. Martinez TY. Impacto da dispneia e parâmetros funcionais respiratórios em medidas de qualidade de vida relacionada a saúde de pacientes com fibrose pulmonar idiopática [thesis]. São Paulo: Universidade Federal de São Paulo; 1998.
 
Electronic Publications

6. Abood S. Quality improvement initiative in nursing homes: the ANA acts in an advisory role. Am J Nurs [serial on the Internet]. 2002 Jun [cited 2002 Aug 12]; 102(6): [about 3 p.]. Available from: http://www.nursingworld.org/AJN/2002/june/Wawatch.htm
 
Homepages/URLs

7. Cancer-Pain.org [homepage on the Internet]. New York: Association of Cancer Online Resources, Inc.; c2000-01 [updated 2002 May 16; cited 2002 Jul 9]. Available from: http://www.cancer-pain.org/

Other situations
In situations other than those mentioned above, authors should follow the ICMJE recommendations (last updated December 2017), available at http://www.icmje.org/recommendations/archives/

Supplementary material
Supplementary material may be added to original articles and review articles. This material should be submitted simultaneously with the main manuscript as a Supplementary File. Supplementary data on methodology and results, including tables, charts, figures, and videos, may be included and will be evaluated by the editors and reviewers. Illustrations added to the supplementary material should be designated (Supplementary Figure 1), (Supplementary Table 1), and so on.
 
IMPORTANT: Supplementary material such as applications, images and sound clips, can be published with your article to enhance it. Submitted supplementary items are published exactly as they are received (Excel or PowerPoint files will appear as such online). Please submit your material together with the article and supply a concise, descriptive caption for each supplementary file. If you wish to make changes to supplementary material during any stage of the process, please make sure to provide an updated file. Do not annotate any corrections on a previous version. Please switch off the 'Track Changes' option in Microsoft Office files as these will appear in the published version.

All correspondence to the JBP should be addressed to:
Marcia Margaret Menezes Pizzichini - Editor-in-Chief
SCS Quadra 01, Bloco K, Salas 203/204 - Ed. Denasa.
CEP 70398-900, Brasília (DF) Brasil.
Tel./Fax: +55 61-3245-1030 or +55 61-3245-6218.

JBP e-mail address
Editorial Manager: Luana Maria Bernardes Campos
jbp@sbpt.org.br